Adherence to Topical Medication in Patients with Inflammatory Eye Disease.
Affiliation
Sandwell and West Birmingham NHS Trust; University of BirminghamPublication date
2020-01-16Subject
Ophthalmology
Metadata
Show full item recordAbstract
Purpose: To evaluate adherence to topical medication in patients with inflammatory eye disease.Methods: Questionnaire survey of patients attending inflammatory eye disease clinics. Treatment regimen was validated against hospital-generated clinic letters.Results: There were 86 patients (52 uveitis and 34 ocular surface disease) with 30% (26/86) failing to identify one or more of the medications they were using, and 28% (24/86) unable to offer the correct indication for their treatment. A total of 64% (55/86) failed to use their medication as advised (27% on a daily basis); the commonest reason being forgetfulness. In patients using multiple eye drops, 26% left insufficient time intervals between successive eye drops, and 58% (50/86) reported not being given any instruction on drop instillation.Conclusions: We highlight poor adherence to topical medication in patients with inflammatory eye disease. We recommend a dedicated practitioner providing a proactive approach to patient education to improve adherence.Citation
Javidi, H., Poonit, N., Patel, R. P., Barry, R. J., Rauz, S., & Murray, P. I. (2021). Adherence to Topical Medication in Patients with Inflammatory Eye Disease. Ocular immunology and inflammation, 29(5), 890–895.Type
ArticlePMID
31944132Publisher
Taylor and Francis Groupae974a485f413a2113503eed53cd6c53
10.1080/09273948.2019.1699122